Abstract
Mathematical modelling is critical for better understanding disease dynamics and developing strategies to manage rapidly spreading infectious diseases. Forecasting is an important aspect of infectious disease modeling, and it is critical for health care planning and disease containment. In this work, we consider a mathematical model of COVID-19 transmission with vaccination where the total population was subdivided into nine disjoint compartments, namely, Susceptible(S), Vaccinated with the first dose(V1), Vaccinated with the second dose(V2), Exposed (E), Asymptomatic infectious (Ia), Symptomatic infectious (Is), Quarantined (Q), Hospitalized (H) and Recovered (R). We computed a reproduction parameter, Rν, using the next generation matrix. Analytical and numerical approach is used to investigate the results. In the analytical study of the model: we showed the local and global stability of disease-free equilibrium, the existence of the endemic equilibrium and its local stability, positivity of the solution, invariant region of the solution, transcritical bifurcation of equilibrium and conducted a sensitivity analysis of the model. From these analyses, we found that the disease-free equilibrium is globally asymptotically stable for Rν < 1 and unstable for Rν > 1. A locally stable endemic equilibrium exists for Rν > 1, which shows the persistence of the disease if the reproduction parameter is greater than unity. The model is fitted to cumulative daily infected cases and vaccinated individuals data of Ethiopia from May 01, 2021 to January 31, 2022. The unknown parameters are estimated using the least square method with the built-in MATLAB function ‘lsqcurvefit’. Finally, we performed different simulations using MATLAB and predicted the vaccine dose that will be administered at the end of two years. From the simulation results, we found that it is important to reduce the transmission rate, infectivity factor of asymptomatic cases and increase the vaccination rate, quarantine rate to control the disease transmission. Long-term simulation results show oscillatory dynamics, indicating that COVID-19 may reemerge. Predictions show that the vaccination rate has to be increased from the current rate to achieve a reasonable vaccination coverage in the next two years.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Our World in Data
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
we updated the Abstract and introduction part. It has been updated the role vaccination on the reproduction number. We also updated the parameter estimation section and the conclusion.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
